Virios' Promising Fibromyalgia Treatment Candidate Expects September 2022 Phase 2b Results
Go back to Virios' Promising Fibromyalgia Treatment Candidate Expects September 2022 Phase 2b Results| (NASDAQ: VIRI) | Delayed: 0.16 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.16 | 52 Week High | $ | |||
| Open | $0.16 | 52 Week Low | $ | |||
| Day High | $0.16 | P/E | N/A | |||
| Day Low | $0.16 | EPS | $ | |||
| Volume | 65,015 | |||||

